Lubbock

Lubbock, TX · LATEST NEWS
Lubbock Avalanche-Journal
Texas Tech HSC doc explores cancer drug's use on Alzheimer’s Disease
November is officially recognized as national Alzheimer’s Awareness Month. As a researcher , I have walked into my laboratory every morning for 16 years focused on preventing, treating and ultimately defeating Alzheimer’s, a disease that affects people’s memory, thinking and behavior. Rigorous scientific research takes time. An ongoing Phase II clinical trial could change how we treat early-stage Alzheimer’s disease. At the Texas Tech University Health Sciences Center (TTUHSC) Laboratory on Neurodegeneration and Translational Research, we are driving a new chapter in Alzheimer’s disease research, collaborating with Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix. Instead of developing a new drug from scratch, we are currently evaluating an existing medication, lenalidomide, used to treat blood and bone marrow cancers. This is part of our ongoing research on repurposing clinically relevant drugs in well-defined studies to accelerate the discovery of the first effective Alzheimer’s treatments capable of stopping disease progression. My journey with this approach began in 2009, after meeting with colleagues from Arizona. For decades, the global scientific community has focused heavily on the abnormal protein accumulations in the brain that define Alzheimer's. These are called amyloid plaques and tau tangles. Our team decided to take a completely